Search

Filter by

Type of content

Include documents

Categories
Document type
Topics
Responsible body
Last updated
First published

Search results (26686)

HBVaxPro
INN or common name: hepatitis B vaccine (recombinant DNA)
Therapeutic area (MeSH): Hepatitis B; Immunization
Marketing authorisation issued:
Last updated: 7 November 2025
Revision: 35
Medicine Human Authorised
Baiama
INN or common name: aflibercept
Therapeutic area (MeSH): Wet Macular Degeneration; Macular Edema; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetes Complications
Marketing authorisation issued:
Last updated: 7 November 2025
Revision: 3
Additional monitoring
Biosimilar
Medicine Human Authorised
Ahzantive
INN or common name: aflibercept
Therapeutic area (MeSH): Wet Macular Degeneration; Macular Edema; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetes Complications
Marketing authorisation issued:
Last updated: 7 November 2025
Revision: 4
Additional monitoring
Biosimilar
Medicine Human Authorised
Gazyvaro
INN or common name: obinutuzumab
Therapeutic area (MeSH): Leukemia, Lymphocytic, Chronic, B-Cell
Marketing authorisation issued:
Last updated: 7 November 2025
Revision: 19
Additional monitoring
Medicine Human Authorised
Vaxxinact H5
INN or common name: Avian influenza virus, subtype H5, haemagglutinin (recombinant)
Opinion adopted:
Last updated: 7 November 2025
Medicine Veterinary Opinion
Ecovaxxin MS
INN or common name: Mycoplasma synoviae, strain K588A, Live
Opinion adopted:
Last updated: 7 November 2025
Medicine Veterinary Opinion
Back to top